1hbt: Difference between revisions

From Proteopedia
Jump to navigationJump to search
← Older editNewer edit →
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,332,606 edits
No edit summary
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,332,606 edits
No edit summary
Line 1: Line 1:
[[Image:1hbt.gif|left|200px]]
{{Seed}}
[[Image:1hbt.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1hbt|  PDB=1hbt  |  SCENE=  }}  
{{STRUCTURE_1hbt|  PDB=1hbt  |  SCENE=  }}  


'''HUMAN ALPHA-THROMBIN COMPLEXED WITH A PEPTIDYL PYRIDINIUM METHYL KETONE CONTAINING BIVALENT INHIBITOR'''
===HUMAN ALPHA-THROMBIN COMPLEXED WITH A PEPTIDYL PYRIDINIUM METHYL KETONE CONTAINING BIVALENT INHIBITOR===




==Overview==
<!--
The crystal structure of a complex between a bivalent peptidyl pyridinium methyl ketone inhibitor and human alpha-thrombin has been solved and refined at 2.0 A to an R factor of 0.18. The inhibitor, (D)cyclohexylalanine-Pro-Arg-(CH2N+C5H4CH2CO)-(Gly)4-Asp- Tyr-Glu-Pro-Ile-Pro-Glu-Glu-Ala-cyclo-hexylalanine-(D)Glu (coded P596), which forms a reversible covalent complex with thrombin, is highly potent with a Ki = 4.6 +/- 1.0 x 10(-14) M, lower than that of recombinant hirudin. The N-terminal, active-site-directed portion of the inhibitor is linked to the fibrinogen recognition exosite binding portion by a tetraglycine segment. The strong electron-withdrawing effect provided by the permanent positive charge on the pyridinium nitrogen makes the arginyl carbonyl carbon more susceptible to nucleophilic attack. In the crystal, a covalent P596-thrombin complex is observed. The electron density surrounding the active site portion and the pyridinium of the inhibitor is very well defined, clearly showing the existence of a covalent bond between the Ser195 O gamma and the now tetrahedral carbon of the inhibitor. The decreased binding ability of thrombin inhibitors containing N-terminal acetylation is discussed as is the effect of replacing the P3 (D)phenylalanine with (D)cyclohexylalanine. The electron density surrounding the remainder of the inhibitor is generally well defined, the exceptions being the C-terminal (D)Glu, the highly flexible tetraglycine linker, and some of the solvent-directed side chains.(ABSTRACT TRUNCATED AT 250 WORDS)
The line below this paragraph, {{ABSTRACT_PUBMED_7547884}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 7547884 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_7547884}}


==About this Structure==
==About this Structure==
Line 26: Line 30:
[[Category: Rehse, P H.]]
[[Category: Rehse, P H.]]
[[Category: Serine protease]]
[[Category: Serine protease]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 18:40:38 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 1 07:57:19 2008''

Revision as of 04:57, 1 July 2008

File:1hbt.png

Template:STRUCTURE 1hbt

HUMAN ALPHA-THROMBIN COMPLEXED WITH A PEPTIDYL PYRIDINIUM METHYL KETONE CONTAINING BIVALENT INHIBITOR

Template:ABSTRACT PUBMED 7547884

About this Structure

1HBT is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Crystal structure of a peptidyl pyridinium methyl ketone inhibitor with thrombin., Rehse PH, Steinmetzer T, Li Y, Konishi Y, Cygler M, Biochemistry. 1995 Sep 12;34(36):11537-44. PMID:7547884

Page seeded by OCA on Tue Jul 1 07:57:19 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "https://proteopedia.org/index.php?title=1hbt&oldid=606393"